Learning Objectives:

    1.  Review denosumab use in osteoporosis management.

    2.  Discuss the rebound phenomenon seen with denosumab discontinuation.

    3.  Review the treatment strategies used to mitigate the rebound phenomenon.

    Session date: 
    05/20/2024 - 5:00pm to 6:00pm CDT
    Add to calendar: 
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
    Please login or create an account to proceed.
    Speaker Name: 
    Leanne Duge, M.D.